Increasing evidence shows that C-reactive protein (CRP) is not only an inflammatory biomarker but also an important risk factor associated with ageing-related diseases including cardiovascular disease, hypertension, diabetes mellitus, and kidney disease.
| INTRODUCTION
With improvement in sanitary conditions, healthcare and nutrition, life expectancy has increased in many populations worldwide. 1 The size of the elderly population aged 80 years or over is projected to increase and triumph in treatment of diseases and public health management, health systems have been increasingly stressed and unequipped to accommodate the living, care and medical needs of the elderly. 3 There is thus a need to better understand the natural process of ageing and its associated physiological and pathophysiological changes to inform and improve health and disease management.
Ageing is a natural phenomenon seen in the presence of a protected environment where survival occurs beyond the natural lifespan of a species, termed essential lifespan (ELS), and is characterised by gradual deterioration of body structure and function. 4 Living well and maintaining healthy mentation, cognitive functions and physical health compatible with independent social activity in the elderly have become important, high-priority goals for many modern societies. Different terms that describe the optimal life status of elderly include healthy ageing, 5 successful ageing 6 and productive ageing, 7 and are commonly seen in published studies where similar meanings are characterised by sustained health, vitality, psychological and social well-being in elderly, although diagnostic criteria of these terms vary. 8 Recently, a meta-analysis by Kim et al. assessed factors related to ageing and identified four aspects that are associated with successful ageing: (i) avoiding disease and disability; (ii) maintaining cognitive, mental and physical functions; (iii) actively engaging in life; and (iv) being psychologically well. 6 Currently, the definition of healthy ageing remains unsettled 6,9 due to differences in diagnostic criteria 10 or depending on the research focus.
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The 24, 25 In this review, we discuss the roles of CRP in ageing, with a focus on its function and mechanisms in physiological or "healthy" ageing, in ageing-related diseases, and in cell signalling. set. The authors found that higher DII scores were associated with CRP ≥3 mg/L and inversely correlated with shorter telomere length.
| CRP AND HEALTHY (SUCCESSFUL) AGEING
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As a surrogate marker of nutritional status, albumin levels were found to be decreased in Japanese centenarians with increased CRP levels. 28 Cognitive decline is common in the elderly and considered a part of the natural ageing process. In a prospective cohort study, serum CRP level was inversely associated with decreased executive function and processing speed within the normal range, 13 whereas a 9-year follow-up study on cognitively intact community-dwelling older women found no difference across tertiles of CRP levels in individuals with faster rates of cognitive decline.
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Physical activity has protective effects on ageing and data have
shown that high levels of house work and recreational activity are independently associated with lower CRP levels in the elderly. 30 In an observational study of 360-day survival in centenarians, higher CRP level was found to be inversely associated with lower survival time. as an additional parameter for ageing assessment that could improve the performance of the healthy ageing index (HAI) in identifying the healthiest older adults. 32 Recently, a study investigating the effect of age on inflammatory markers in 2944 healthy women aged 30-79 years found that age was positively correlated with CRP level. 33 
| CRP AND AGEING-RELATED DISEASE
In the current literature, the common ageing-related diseases and conditions associated with increased CRP levels include CVD, [15] [16] [17] 
| Cardiovascular disease
Advancing age is an important non-modifiable risk factor for CVD. The incidence of CVD increases with advancing age. 35 High incidence of CVD in the elderly represents an interaction between age, cardiovascular risk factors and genetic predisposition. 36 Studies have shown that CRP is a strong predictor of CVD in older adults without baseline CVD. 37 CRP level is associated with incident cardiovascular events including angina pectoris, myocardial infarction, and death in the elderly, especially in those with subclinical disease at baseline. 15 In the appropriate clinical context, elevated CRP levels can serve as a biomarker for advanced atherosclerosis and heightened risk for future acute cardiovascular events, warranting statin therapy for risk reduction. 38 Increased CRP level is also associated with poor physical functioning in the elderly, 39 subnormal levels of sex hormones (possibly indicative of CVD risks, depending on the hormone), 40 and metabolic syndrome. 41, 42 However, CRP should not be used as a sole predictor of CVD in the elderly and its performance can vary in different clinical settings. 43 
| Diabetes mellitus
C-reactive protein is an independent risk factor for impaired fasting glucose, impaired glucose tolerance and diabetes in older adults.
Elevated haemoglobin A1c (HbA1c, %) is significantly associated with a higher CRP level even after adjustment 20 as seen in type 2 diabetes.
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Both blood glucose level and HbA1c are positively correlated with circulating levels of CRP in elderly subjects aged 85 years. 45 Compared with subjects with normal fasting glucose, diabetic patients and those with impaired fasting glucose level (defined by a glucose threshold level of 110 mg/dL) and/or elevated plasma glucose level at 2 hours of oral glucose tolerance test have significantly higher CRP levels. 46, 47 Increased CRP is also associated with injury to the kidneys reflected by microalbuminuria as a complication in patients with diabetes. 
| Parkinson's disease
Parkinson's disease is a common neurodegenerative disorder exacerbated by ageing. 49 The loss of striatal dopaminergic neurons is aetiologic to the pathogenesis of idiopathic Parkinson's disease during the ageing process. 50 Available evidence shows that chronic inflammation is instrumental to its pathogenesis. 51 This is supported by findings that serum CRP levels are significantly higher in older adults with
Parkinson's disease compared with healthy controls. 34, 52 Parkinson's disease patients with higher CRP tended to be older and have a higher incidence of CVD. 53 Patients with more severe Parkinson's disease classified by the Hoehn-Yahr staging system have significantly higher levels of CRP than those at an earlier stage, and compared with nonParkinson's control subjects.
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A cross-sectional study showed that CRP plays a key functional role in the pathogenesis of Parkinson's disease and may be used to assess its severity. 55 Additional data demonstrated that CRP levels in drug-naive patients with early Parkinson's disease are higher than healthy controls and the odds ratio (risk) for Parkinson's disease based on CRP level cut-off of 0.5 was 2.094 (95% CI 1.017-4.311, P = .045). 56 Furthermore, high baseline CRP levels are associated with motor deterioration in Parkinson's disease patients and these associations are independent of age, sex, disease severity, dementia, and anti-Parkinsonian agents used. 
| Alzheimer's disease
Alzheimer's disease is a neurodegenerative disorder characterised by gradually progressive cognitive decline and functional impairment. 65 In an in vitro study, CRP at a level seen in inflammatory states (50 μg/mL) produced direct toxicity to human-derived neuronal cell line. These results suggest a direct functional effect elicited by CRP and may be explanatory for, at least in part, the pathogenesis of Alzheimer's disease. 66 However, data to support this are scarce, and a direct inference based on comparative CRP levels should not be made with respect to the pathogenesis of Alzheimer's disease.
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| Chronic kidney disease
A large prospective study reported that estimated glomerular filtration rate (eGFR) declined with increasing age, and that age is an important risk factor for renal impairment. 
| PATHOGENIC MECHANISMS OF CRP IN AGEING
The process of ageing, with or without ageing-related disease(s), involves a complex interplay between many cellular and molecular signalling mechanisms. Accumulating evidence suggests that aberrant and maladaptive cellular and molecular events contribute to ageing and ageing-related disease(s). The transforming growth factor-beta (TGF-β)/Smad3 signalling pathway plays a critical role in disease, healing and in maintaining physiological homeostasis. The pathway is vitally important in inflammation, tissue repair, and the transition between inflammation and fibrosis. As shown in Figure 1 , CRP binds its receptors FcγRII (CD32/CD64) to activate directly or interact with a
The pathogenic mechanisms of C-reactive protein (CRP) in ageing. CRP binds FcγRII and activates TGF-β/Smad3 and non-TGF-β/Smad3 signalling pathways directly and indirectly to induce inflammation and fibrosis, impairing the ability of cell proliferation, and contributes to the process of ageing number of signalling pathways in the process of inflammation, fibrosis, and ageing.
In our previous studies, we investigated the role of CRP in the progression of ageing-related kidney disease in human CRP transgenic (tg) mice and tubular epithelial cell treated with human CRP.
Our data showed that CRP was not only a marker of inflammation but also a mediator of kidney injury. Through an acute ischaemiareperfusion kidney injury model in human CRPtg mice, 71, 72 
| Other mechanisms
As demonstrated in our previous studies, CRP can activate ERK/p38
MAPK and NF-κB signalling to promote inflammation in kidney tissue. 72, 73 Other studies have shown that CRP can induce plasminogen 
